nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilastatin—SLC22A8—Methotrexate—testicular cancer	0.26	0.589	CbGbCtD
Cilastatin—DPEP1—gonad—testicular cancer	0.183	0.327	CbGeAlD
Cilastatin—SLC22A6—Methotrexate—testicular cancer	0.181	0.41	CbGbCtD
Cilastatin—DPEP1—female gonad—testicular cancer	0.149	0.266	CbGeAlD
Cilastatin—DPEP1—testis—testicular cancer	0.132	0.236	CbGeAlD
Cilastatin—DPEP1—lymph node—testicular cancer	0.0955	0.171	CbGeAlD
